BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2354 related articles for article (PubMed ID: 32771890)

  • 1. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquiritigenin inhibits hepatic fibrogenesis and TGF-β1/Smad with Hippo/YAP signal.
    Lee EH; Park KI; Kim KY; Lee JH; Jang EJ; Ku SK; Kim SC; Suk HY; Park JY; Baek SY; Kim YW
    Phytomedicine; 2019 Sep; 62():152780. PubMed ID: 31121384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
    Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
    Choi YJ; Kim DH; Kim SJ; Kim J; Jeong SI; Chung CH; Yu KY; Kim SY
    Life Sci; 2014 Jul; 108(2):94-103. PubMed ID: 24880074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways.
    Cheng Q; Li C; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW; Li L
    Chem Biol Interact; 2019 Feb; 299():131-139. PubMed ID: 30543783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
    Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
    Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
    Perumal N; Perumal M; Halagowder D; Sivasithamparam N
    Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro.
    Tang LX; He RH; Yang G; Tan JJ; Zhou L; Meng XM; Huang XR; Lan HY
    PLoS One; 2012; 7(2):e31350. PubMed ID: 22363627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
    Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
    World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 Scaffolding Domain Peptides Alleviate Liver Fibrosis by Inhibiting TGF-β1/Smad Signaling in Mice.
    Lu J; Zhang J; Wang Y; Sun Q
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Geniposide inhibits hepatic fibrosis and hepatic stellate cell activation through blocking the TGF-β1/Smad signaling pathway].
    Zhou LH; Chen X
    Sheng Li Xue Bao; 2022 Apr; 74(2):217-224. PubMed ID: 35503069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
    Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
    J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Praziquantel ameliorates CCl
    Liu J; Kong D; Qiu J; Xie Y; Lu Z; Zhou C; Liu X; Zhang R; Wang Y
    Br J Pharmacol; 2019 Dec; 176(24):4666-4680. PubMed ID: 31412137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
    Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
    Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
    Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
    Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-n-Butyl haloperidol iodide ameliorates liver fibrosis and hepatic stellate cell activation in mice.
    Shen DF; Cheng H; Cai BZ; Cai WF; Wang B; Zhu Q; Wu YB; Liu M; Chen RJ; Gao FF; Zhang YM; Niu YD; Shi GG
    Acta Pharmacol Sin; 2022 Jan; 43(1):133-145. PubMed ID: 33758354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor-
    Qiu JL; Zhang GF; Chai YN; Han XY; Zheng HT; Li XF; Duan F; Chen LY
    J Pharmacol Exp Ther; 2022 Jun; 381(3):257-265. PubMed ID: 35398813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chrysin attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
    Balta C; Herman H; Boldura OM; Gasca I; Rosu M; Ardelean A; Hermenean A
    Chem Biol Interact; 2015 Oct; 240():94-101. PubMed ID: 26297989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amygdalin Ameliorates Liver Fibrosis through Inhibiting Activation of TGF-β/Smad Signaling.
    Xiao Z; Ji Q; Fu YD; Gao SQ; Hu YH; Liu W; Chen GF; Mu YP; Chen JM; Liu P
    Chin J Integr Med; 2023 Apr; 29(4):316-324. PubMed ID: 34816365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 118.